Revolution Medicines, Inc. (RVMD) NASDAQ

40.65

+1.25(+3.17%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap7.34B
Enterprise Value6.93B
P/E Ratio-10.96
PEG Ratio0.91
Price/Sales Ratio28.95
Price/Book Ratio3.68
Enterprise/Revenue28.18
Enterprise/EBITDA-9.44

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-2.67
Operating Margin-3.02

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.37

Income Statement

Revenue0
Revenue/Share1.39
Gross Profit0
EBITDA-589.02M
Net Income-600.09M
Diluted EPS-3.58

Balance Sheet

Total Cash2.1B
Total Cash/Share11.18
Total Debt134.34M
Total Debt/Equity0.06
Current Ratio13.46
Book Value Per Share11.05

Price History

52-Week Change1.19
52-Week High62.4
52-Week Low29.17
Moving Average 50 Days37.77
Moving Average 200 Days43.63

Statistics

Average Volume1.84M
Shares Outstanding186.27M
% Held by Institutions101.55

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A